The Business Exchange Swindon & Wiltshire Edition 43: June/July 2019 | Page 5

BUSINESS NEWS TWO WILTSHIRE FIRMS RECOGNISED IN THE HIGHLY COVETED QUEEN’S AWARDS FOR ENTERPRISE Brinkworth firm Chipside and Marlborough based Foregenix have been awarded the Queen’s Award for Enterprise and Innovation. The Queen’s Awards for Enterprise is an awards programme for British businesses and other organisations that excel in three categories; International Trade, Innovation and Sustainable Development. The awards are the highest official UK accolade for British businesses and aim to promote excellence and drive economic growth. Chipside, a provider of parking and traffic management IT was selected for its outstanding achievement and commercial success in innovation. Founded in 2003 and employing 50 people, Chipside is a specialist software development company providing digital ticketing and permitting products and services to more than half of all local and national government authoritites in the UK. Paul Moorby OBE, CEO of Chipside, said, “Winning a Queen’s Award for Enterprise: Innovation is a fantastic achievement for our company and welcome recognition for the hard work and results I have seen from my team in recent years. “We have worked hard to digitally transform local government and this is why we continually reinvest in innovation to improve our software suite, introducing new services to customers such as back office notice processing and MiPermit digital permits. We look forward to moving forward and continuing to build upon our success, growing as a tech company and improving our services to meet the potential of the UK’s connected cities.” Foregenix received the award for its work in international trade. It is the first cyber security consultancy with a focus on protecting the payment and finance industries to receive the honour. The specialist firm, which celebrated its 10th birthday in March, generated around 60% of its revenue from international sales over the past four years, helped by new offices in Boston, Sydney, Frankfurt, São Paulo and Singapore. Foregenix offers a range of services including managed detection and response services, digital forensics, compliance and risk services. It is the world’s leading certification company for payment systems on point-to-point encryption and a global Paul Moorby OBE, CEO of Chipside (left) Left to right: Paul Humpage, Andrew Henwood, Benjamin Hosack. authority on ATM cashout attacks. Co- founder and Chief Technology Officer Andrew Bontoft said, “It is testimony to the brilliant work and dedication of our global team, that we’ve received this prestigious award. We are very proud of what the team has achieved and grateful for the recognition this award signifies. We would also like to thank our clients and suppliers for helping us achieve this honour.” CEO Andrew Henwood added, “Foregenix aims to protect businesses and organisations from criminals who attempt to endanger people’s livelihoods and futures, for their own enrichment. It is a cause that resonates with our customers, offering practical advice, baked in security and tangible risk reduction globally. We are incredibly humbled to be recognised for this prestigious award.” For more information about Chipside visit: www.chipside.com And for more about Foregenix go to: www.foregenix.com Catalent to invest £20 million in Swindon Catalent Pharma Solutions, a leading pharmaceutical development company, has announced it is to invest more than £20 million in its development and manufacturing site in Swindon adding up to 100 jobs. The site is home to the company’s Zydis ® technology which allows for the manufacture of tablets that dissolve instantly in the mouth without water and is used in many prescription and over- the-counter medicines to treat conditions including Parkinson’s disease, allergies and travel sickness. The investment will see the site almost double its manufacturing capacity for tablets as it introduces a new variation called Zydis ® Ultra. The new technology will significantly increase the dose that can be incorporated within a tablet, allowing more treatments to benefit from this convenient and patient- friendly dose form. Peter Allen, General Manager at Catalent Swindon, said, “The medicines that we make in Swindon help patients all around the world to live better healthier lives. “Zydis technology is incorporated into many prescription medicines and popular over-the-counter brands. We are very proud of the scientific team that we have here that continues to develop this revolutionary technology, allowing us to grow and widen the number of potentially life-changing conditions it can treat.” Catalent’s facility in Blagrove Swindon employs over 650 people and manufactures 1.2 billion individual doses of medicines for patients around the world each year. To date more than 36 products have been launched using Zydis technology in more than 60 countries. Chair of Switch on to Swindon, Jenny Groves, added, “It’s fantastic to hear that Catalent are looking to expand their already hugely successful business in Swindon. Swindon prides itself on being consistently one of the most innovative places in the U.K. and the pharmaceuticals industry generally Peter Allen, General Manager, Catalent Swindon and Catalent specifically have played a huge part in this. Catalent are a successful global organisation offering exciting careers for the talent in and around Swindon and we’re hugely proud they’re part of our vibrant economy.” Industry leading document & print management solutions Headquartered in Bath since 1984 0845 688 6868 [email protected] www.1st-office.com THE BUSINESS EXCHANGE 2019 5